Can improving liver health help protect the heart? Duke GI researcher @AmreenDinani leads a novel clinical trial studying whether Resmetirom can impact both MASH & heart failure, helping redefine metabolic disease as a whole-body condition. #MASH #HFpEF du.ke/p/h5kh
Duke GI
@Duke_GI_
Leader in GI Patient Care, Education, and Research
Duke GI on LinkedIn: duke.is/GILI
Duke GI on LinkedIn: duke.is/GILI
1.3K Following 3.7K Followers 13K Posts
Latest posts 5
Duke GI is pleased to announce that Dr. Zachary Lorsch has received the 2026 Malcolm P Tyor Award! Established in 1990, this prestigious award supports junior GI faculty in their pursuit of research careers.
Congratulations, @ZachLorschMDPhD, on this well-deserved recognition 👏
Congratulations, @ZachLorschMDPhD, on this well-deserved recognition 👏
Proud to see @CindyMoylan_MD highlighting the evolving treatment landscape for MASLD/MASH!
Dr. Cynthia Moylan (@Duke_GI_) discusses New and Emerging Pharmacotherapy for MASLD/MASHView quoted post on X
There are no GLP-1 receptors in the liver ➡️ semaglutide works indirectly
Multiple targets for new drugs identified
🥁Williamsburg
Congratulations to Dr. Stan Branch, recipient of the 2026 Dawn Provenzale Mentorship Award in Gastroenterology! Dr. Branch is recognized for his commitment to excellence in mentoring & his lasting impact on the next generation of clinicians & the Duke GI community. #GIGoodNews
A milestone for Duke GI! Elizabeth Goacher, PA, has been appointed Medical Director of Duke GI Clinic 2J, the first Advanced Practice Provider to serve as a med dir in Duke GI.
Congratulations, @GoachPA_DukeGI on this achievement & for breaking new ground in clinical leadership.
Congratulations, @GoachPA_DukeGI on this achievement & for breaking new ground in clinical leadership.